In parallel to a lower percentage of CD14++CD16− monocytes (71.3% ± 6.5 vs. 77.3% ± 3.4; P < 0.05), a corresponding higher percentage of CD14++CD16+ monocytes (7.2% ± 2.6 vs. 4.0% ± 1.4; P < 0.005) and CD14+CD16++ monocytes (12.6% ± 6.2 vs. 7.2% ± 2.8; P < 0.05) was observed in HD patients compared to control (Ctrl). Here, CD14 is linked to Huntington disease.